Teva's Bid To Duck MDL Trials Slammed As 'Fool's Errand'
Law360 (November 23, 2020, 11:05 PM EST) -- A group of drug buyers and states asked a Pennsylvania federal judge Friday to reject Teva Pharmaceutical's bid to scrap a bellwether trial in multidistrict litigation over civil price-fixing claims to await the outcome of related criminal charges, calling the drugmaker's efforts to keep witnesses from overlapping a "fool's errand."
The buyers and the states said Teva's concerns that its Fifth Amendment rights will be violated if witnesses are deposed simultaneously in both civil and criminal cases are not unusual. Those concerns will persist regardless of the order in which the cases move forward, because there are overlapping defendants and witnesses across the...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!